24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL Study
Crossref DOI link: https://doi.org/10.1007/s12325-020-01496-7
Published Online: 2020-10-03
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lipson, David A.
Birk, Ruby
Brealey, Noushin
Zhu, Chang-Qing
Text and Data Mining valid from 2020-10-03
Version of Record valid from 2020-10-03
Article History
Received: 7 July 2020
Accepted: 3 September 2020
First Online: 3 October 2020